Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.
about
Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized TrialsIntegrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South AfricaEvolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-NatalCost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaA Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant TuberculosisGenomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis.How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.Target product profile of a molecular drug-susceptibility test for use in microscopy centers.Outcomes of isoniazid prophylaxis among HIV-infected children attending routine HIV care in Kenya.How competition governs whether moderate or aggressive treatment minimizes antibiotic resistanceBenefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.Population dynamics of epidemic and endemic states of drug-resistance emergence in infectious diseases.Response to comment on "Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis".Comment on "Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis".Mathematical Models for the Epidemiology and Evolution of Mycobacterium tuberculosis.Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting
P2860
Q26778385-0136CE88-5DCC-415E-B7AA-E952E385B083Q28547001-9C38FB5B-07E8-46A5-A822-FB62F183EC4DQ28548604-4FB6CCB6-7E2F-4D52-8AD4-1AD6E9D61E1AQ28554655-8963AF10-BD42-431A-A215-F369A1D65111Q29048653-B9DBAB47-1B9E-441E-B86E-EC4C016D64BFQ33595994-30AD741C-E9E7-4373-B36F-166BF9D371FCQ35098753-E95F3683-684B-463D-BDD1-FDB029F342F1Q35583501-4E4639BD-0623-4EE7-9C5A-7C32ADB83D67Q35588123-03E23433-CD99-4E8B-ADA4-E348A96A4FA2Q35719333-401E1E9A-B631-40E4-89A3-6D7D81D69BA9Q36270884-3CB56695-4259-4850-86C3-1093ECF38C6DQ38805328-91FA3F98-714D-4816-9F78-DDCE267B9155Q40368149-72B7D5A6-DF61-4090-ABD5-4DC391314934Q43706761-180FC5A9-C550-4FEE-8676-E744E770C28EQ46325068-AF0E496D-8EC9-4D6F-A9D2-409B82B4717AQ47369329-4A158B47-0D4A-4E85-ACB4-1AE06EB3B43CQ58718315-7E96A631-A23D-4A5D-A972-FCD7C5F85214
P2860
Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Community-wide isoniazid preve ...... losis: a model-based analysis.
@en
Community-wide isoniazid preve ...... losis: a model-based analysis.
@nl
type
label
Community-wide isoniazid preve ...... losis: a model-based analysis.
@en
Community-wide isoniazid preve ...... losis: a model-based analysis.
@nl
prefLabel
Community-wide isoniazid preve ...... losis: a model-based analysis.
@en
Community-wide isoniazid preve ...... losis: a model-based analysis.
@nl
P2860
P1476
Community-wide isoniazid preve ...... losis: a model-based analysis.
@en
P2093
Harriet L Mills
P2860
P304
P356
10.1126/SCITRANSLMED.3005260
P407
P577
2013-04-01T00:00:00Z